Filing Details

Accession Number:
0001104659-23-124678
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-08 16:05:24
Reporting Period:
2023-12-07
Accepted Time:
2023-12-08 16:05:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1400118 Sagimet Biosciences Inc. SGMT Pharmaceutical Preparations (2834) 205991472
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1623567 David Happel Sagimet Biosciences Inc.
155 Bovet Rd., Suite 303
San Mateo CA 94402
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Series A Common Stock Acquisiton 2023-12-07 1,600 $4.10 627,100 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.02 per share to $4.16 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each price.